Meeting NewsVideo

VIDEO: Pembrolizumab represents ‘important option’ for metastatic urothelial cancer

June 25, 2017
CHICAGO — Improvements in response duration and side effect profile seen in the KEYNOTE-045 trial of pembrolizumab establish this therapy…

The Wistar Institute appoints associate professor

June 25, 2017
The Wistar Institute appointed Daniel W. Kulp, PhD, as associate professor in its vaccine center and translational tumor immunology program…

University of Alabama at Birmingham appoints cancer center director

June 24, 2017
Michael J. Birrer, MD, PhD, has been named director of University of Alabama at Birmingham Comprehensive Cancer Center. Birrer’s appointment…
Meeting NewsVideo

VIDEO: Questions remain regarding use of gene-targeted therapy for lung cancer

June 23, 2017
CHICAGO — Suresh S. Ramalingam, MD, deputy director of Winship Cancer Institute of Emory University, discusses the results of a phase 3 trial…

10 updates in immunotherapy research

June 23, 2017
In recognition of Cancer Immunotherapy Month, Cancer Research Institute has organized a series of educational and social events designed to raise…
FDA News

FDA approves BevyxXa for prevention of venous thromboembolism

June 23, 2017
The FDA granted approval to betrixaban for the prevention of venous thromboembolism and pulmonary embolism in acutely ill patients who are not…
In the Journals Plus

Midostaurin extends survival in acute myeloid leukemia with FLT3 mutation

June 23, 2017
The addition of midostaurin to standard chemotherapy improved OS and EFS among patients with acute myeloid leukemia and FLT3 mutation, according to…

High-dose vitamin C may increase efficacy of cancer therapies

June 23, 2017
The addition of high-dose vitamin C to standard chemotherapy or radiation appeared to effective and safe for patients with glioblastoma multiforme…
In the Journals Plus

Mood, quality of life worse in newly diagnosed incurable cancer

June 23, 2017
Awareness of prognosis appeared associated with worse mood and quality of life among patients newly diagnosed with incurable cancer, study data

Focused Ultrasound Foundation, Cancer Research Institute partner to advance immunotherapy research

June 23, 2017
Focused Ultrasound Foundation and Cancer Research Institute will partner to advance the research and development of new focused ultrasound and cancer…
Meeting NewsVideo

VIDEO: Adam Brufsky, MD, PhD, discusses results of MONARCH-2, PALOMA-1 trials

June 23, 2017
Adam M. Brufsky, MD, PhD, professor of medicine and co-director of the Comprehensive Breast Cancer Center at the University of Pittsburgh, discusses…
Meeting NewsVideo

VIDEO: High-intensity genomic assay may help ‘unlock mysteries’ in lung cancer treatment

June 23, 2017
CHICAGO — Edward S. Kim, MD, chair of solid tumor oncology and investigational therapeutics at the Levine Cancer Institute, and a HemOnc
FDA News

FDA approves Tafinlar plus Mekinist for BRAF V600E–mutant non–small cell lung cancer

June 22, 2017
The FDA approved use of dabrafenib in combination with trametinib for treatment of patients with metastatic non–small cell lung cancer whose…
Meeting NewsVideo

VIDEO: Updated KEYNOTE-024 results raise question in sequencing of lung cancer treatments

June 22, 2017
CHICAGO — Hossein Borghaei, DO, chief of the division of thoracic medical oncology at Fox Chase Cancer Center, discusses the updated…
FDA News

FDA approves Rituxan Hycela subcutaneous injection for blood cancers

June 22, 2017
The FDA approved Rituxan Hycela subcutaneous injection to treat three blood cancers. Rituxan Hycela (Genentech) — a combination of rituximab…

Senate health care bill takes slower approach to House bill, expert concerns persist

June 22, 2017
The Senate health care bill, released to the public today, maintains much from the version the House passed May 4, 2017, but presents some key…
In the Journals Plus

Cost of hospital-based end-of-life care high for elderly with brain tumors

June 22, 2017
Hospital-based end-of-life care for elderly patients with malignant brain tumors is associated with up to $16,000 in expenses, according to a…
In the Journals Plus

Additional screening improves detection of new breast cancers following surgery

June 22, 2017
The addition of MRI or ultrasonography to annual mammography…

Companies collaborate to evaluate immunotherapy regimen for colorectal cancer

June 22, 2017
Three companies — eFFECTOR Therapeutics, Pfizer and Merck KGaA — entered a clinical collaboration to evaluate the combination of eFT508…
Meeting News

Point of care screening model outperforms conventional breast cancer screening methods

June 22, 2017
PHILADELPHIA — Health care providers who followed a point of care integrated breast cancer screening model referred more patients, and had more…
Advertisement
Advertisement